BioVie Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
BioVie Inc. (BIVI) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $1.80 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2017-11-08
- 2017-09-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $1.80M.
- 2016-09-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $1.36M.
- 2016-06-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $2.34M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $1.00M.
- 2016-03-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $734.70K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2017-09-30 | $1.80M 10-Q · filed 2017-11-08 | |
| 2016-09-30 | $1.36M 10-Q/A · filed 2017-01-19 | |
| 2016-06-30 | $2.34M 10-K · filed 2017-08-24 | $1.00M 10-K · filed 2016-09-28 |
| 2016-03-31 | $734.70K 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $676.90K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $572.40K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $572.40K 10-K · filed 2015-10-01 | |
| 2015-03-31 | $494.20K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $445.30K 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $398.20K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $339.40K 10-K · filed 2014-09-24 | |
| 2014-03-31 | $163.70K 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |